FDA Inspection
Evofem Biosciences Inc.Evofem Biosciences Inc. – FDA Inspection, Sep 11, 2026
Record Details
This FDA Inspection record concerns Evofem Biosciences Inc., with an inspection on September 11, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 26179937-7cf2-4719-ad64-c79c76cdc38d
Inspection Facts
- Inspection number
- 1300796
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
- 21 CFR 314.81(b)(2)Timely submission
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Evofem Biosciences Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2015 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| November 28, 2012 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Evofem Biosciences Inc.
- FDA Inspection 940944 - 2015-08-28
- FDA Inspection 808507 - 2012-11-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.